ZDHHC11-mediated palmitoylation alleviates chondrocyte senescence and serves as a therapeutic target for osteoarthritis
8.0
来源：
Nature
关键字：
mRNA
发布时间：
2025-09-30 23:40
摘要：
ZDHHC11 is identified as a critical palmitoyltransferase that plays a protective role in osteoarthritis (OA) by preventing chondrocyte senescence and promoting cartilage anabolism. The study demonstrates that ZDHHC11 expression is downregulated in OA, and its restoration can ameliorate OA symptoms. A novel lipid nanoparticle-based delivery system for Zdhhc11 mRNA is proposed, showing promise for targeted therapy in OA treatment. This research highlights the potential of ZDHHC11 as a therapeutic target, addressing a significant unmet need in OA management.
原文：
查看原文
价值分投票
评分标准
新闻价值分采用0-10分制，综合考虑新闻的真实性、重要性、时效性、影响力等多个维度。
评分越高，表示该新闻的价值越大，越值得关注。
价值维度分析
domain_focus
1.0
business_impact
1.0
scientific_rigor
1.5
timeliness_innovation
1.5
investment_perspective
2.5
market_value_relevance
1.0
team_institution_background
0.5
technical_barrier_competition
0.5
关键证据
ZDHHC11 is highly expressed in articular chondrocytes and prevents chondrocyte senescence.
The study proposes a lipid nanoparticle-based platform for Zdhhc11 mRNA delivery.
ZDHHC11-mediated palmitoylation alleviates OA progression by deactivating the GATA4–P65 signaling pathway.
真实性检查
否
AI评分总结
ZDHHC11 is identified as a critical palmitoyltransferase that plays a protective role in osteoarthritis (OA) by preventing chondrocyte senescence and promoting cartilage anabolism. The study demonstrates that ZDHHC11 expression is downregulated in OA, and its restoration can ameliorate OA symptoms. A novel lipid nanoparticle-based delivery system for Zdhhc11 mRNA is proposed, showing promise for targeted therapy in OA treatment. This research highlights the potential of ZDHHC11 as a therapeutic target, addressing a significant unmet need in OA management.